期刊文献+

2010-2012年我院抗真菌药物使用分析 被引量:2

Application of Antifungal Agents in A Hospital from 2010 to 2012
下载PDF
导出
摘要 目的分析评价我院2010—2012年抗真菌药物利用情况。方法通过医院信息管理系统,对我院2010—2012年抗真菌药的销售金额和数量进行统计分析,并计算用药频率(DDDs)及药品日均费用(DDC)。结果我院2010-2012年抗真菌药物总销售金额逐年增加。销售总金额前2位的是伏立康唑和氟康唑,DDDs排序靠前的主要是特比萘芬和伊曲康唑。DDC呈逐年下降。结论我院抗真菌药物临床应用较为合理,三唑类是临床使用最广泛的抗真菌药。部分品种存在不合理使用现象,需加强监管。 Objective To investigate the application of antifungal agents in Tongde hospital from 2010 to 2012. Methods Sales amount of antifungal agents in our hospital from the period of 2010 to 2012 were statistically an-alyzed with data retrieved from the hospital information management system and defined daily doses (DDDs) and defined daily cost(DDC) were calculated. Result The total cost of antifungal agents in our hospital increased year by year from 2010 to 2012. Voriconazole and fluconazol were in the top of sum and terbinafine and itraconazole were in the top of DDDs. DDC was decreased year by year. Conclusion Clinical application of antifungal agents in our hospital was appropriate; triazole was the most widely used antifungal agent. Inappropriate application of some varieties of antifungal agents was also noted and should be supervised.
出处 《浙江中西医结合杂志》 2014年第1期20-22,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
基金 浙江省医学会临床科研资金项目(No.2011ZYC-A08)
关键词 抗真菌药物 药物利用 用药频度 日均费用 antifungal agents drug utilization defined daily doses defined daily cost
  • 相关文献

参考文献5

二级参考文献36

  • 1胡庆丰,吕火祥,丁玎.252株深部真菌的鉴定和耐药性分析[J].浙江临床医学,2004,6(7):579-579. 被引量:1
  • 2周竹超,倪泉兴,吴菊芳,章强强.普外科真菌感染84例临床调查[J].中国抗感染化疗杂志,2004,4(4):219-222. 被引量:11
  • 3段蕴铀.全国14家医院抗菌药物合理用药调研[J].天津药学,2005,17(1):23-25. 被引量:26
  • 4蔡卫民,吕迁洲,张建中,丰家驹,史美玉,余自成,陶静,金知萍,叶晓芬,杨其莲.2005年上半年上海地区抗菌药物使用调查分析[J].药物流行病学杂志,2006,15(4):227-230. 被引量:36
  • 5MF, NICHETTI F, del FAVERO A, MARTINO P, et al. Itraconazole oral solution as prophylaxis for fungal infections in neutropenie patients with hemalologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial[J]. Clin Infect Dis, 1999, 28(2) :250-255.
  • 6HAROUSSEAU JL. DEKKER AW, STAMATOULLAS-BASTARD A, et al. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B[J]. Antimicrob Agents Chemother, 2000, 44(7) : 1887-1893.
  • 7MORGENSTERN GR, PRENTICE AG, PRENTICE HG, et al.A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies[J]. Br J Haematol, 1999, 105(4):901-911.
  • 8WINSTON DJ, MAZIARZ RT, CHANDRASEKAR PH, et al.Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter,randomized trial[J]. Ann Intern Med, 2003, 138(9): 705-713.
  • 9MARR KA, CRIPPA F, LEISENRING W, et al. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants[J]. Blood, 2004, 103(4): 1527-1533.
  • 10GOTZSCHE PC, JOHANSEN HK, Routine versus selective antifungal administration for control of fungal infections in patientswith cancer[J]. Cochrane Database Syst Rev, 2002, (2):CD00-0026.

共引文献338

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部